adenine has been researched along with Amazon Black Fever in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Long-term safety of treatment with hepatitis B virus (HBV) polymerase inhibitors is a concern." | 6.77 | Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infection. ( Bozkaya, H; Cakaloglu, Y; Chatzikyrkou, C; Dalekos, GN; Erhardt, A; Großhennig, A; Gurel, S; Manns, MP; Mederacke, I; Wedemeyer, H; Yalcin, K; Yurdaydin, C; Zachou, K; Zeuzem, S, 2012) |
| " Treatment naive chronic hepatitis C patients should initially receive pegylated interferon and ribavirin dual combination therapy." | 3.78 | [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis]. ( Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I; Ujhelyi, E, 2012) |
| "Long-term safety of treatment with hepatitis B virus (HBV) polymerase inhibitors is a concern." | 2.77 | Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infection. ( Bozkaya, H; Cakaloglu, Y; Chatzikyrkou, C; Dalekos, GN; Erhardt, A; Großhennig, A; Gurel, S; Manns, MP; Mederacke, I; Wedemeyer, H; Yalcin, K; Yurdaydin, C; Zachou, K; Zeuzem, S, 2012) |
| "Specialized treatment of CHB in pregnancy, coinfection, decompensated cirrhosis, and posttransplant is safe and effective." | 2.48 | New advances in chronic hepatitis B. ( Lee, WM; Tujios, SR, 2012) |
| "We describe an acute hepatitis D virus superinfection in an HIV-1-infected patient under HAART treatment who was previously a chronic carrier of a surface negative HBV variant resistant to lamivudine." | 1.33 | Hepatitis delta virus super-infection in a co-infected patient with the human immunodeficiency virus type 1 and a surface antigen-negative hepatitis B virus variant. ( Alloui, C; Bouhassoune, K; Calboreanu, A; Dény, P; Gordien, E; Legal, F; Podevin, P; Rico-Garcia, M; Salmon-Céron, D; Sogni, P, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Hercun, J | 1 |
| Koh, C | 1 |
| Heller, T | 1 |
| Soriano, V | 2 |
| Poveda, E | 1 |
| Vispo, E | 1 |
| Barreiro, P | 2 |
| James, G | 1 |
| Sidhu, P | 1 |
| Raza, M | 1 |
| de Mendoza, C | 1 |
| Gervain, J | 2 |
| Horváth, G | 2 |
| Hunyady, B | 2 |
| Makara, M | 2 |
| Pár, A | 2 |
| Szalay, F | 2 |
| Tornai, I | 2 |
| Telegdy, L | 2 |
| Genzini, T | 1 |
| Dos Santos, RG | 1 |
| Pedrosa, C | 1 |
| Curvelo, LA | 1 |
| Noujaim, HM | 1 |
| Crescentini, F | 1 |
| Mota, LT | 1 |
| Guirro, TG | 1 |
| Ferreira, FY | 1 |
| Salomão, P | 1 |
| Pereira, JR | 1 |
| de Miranda, MP | 1 |
| Ciancio, A | 1 |
| Rizzetto, M | 1 |
| Mederacke, I | 2 |
| Yurdaydin, C | 2 |
| Dalekos, GN | 2 |
| Bremer, B | 1 |
| Erhardt, A | 2 |
| Cakaloglu, Y | 2 |
| Yalcin, K | 2 |
| Gurel, S | 2 |
| Zeuzem, S | 2 |
| Zachou, K | 2 |
| Bozkaya, H | 2 |
| Dienes, HP | 1 |
| Manns, MP | 2 |
| Wedemeyer, H | 2 |
| Ujhelyi, E | 1 |
| Tujios, SR | 1 |
| Lee, WM | 1 |
| Großhennig, A | 1 |
| Chatzikyrkou, C | 1 |
| Babiker, ZOE | 1 |
| Hogan, C | 1 |
| Ustianowski, A | 1 |
| Wilkins, E | 1 |
| Gordien, E | 1 |
| Bouhassoune, K | 1 |
| Calboreanu, A | 1 |
| Alloui, C | 1 |
| Rico-Garcia, M | 1 |
| Salmon-Céron, D | 1 |
| Legal, F | 1 |
| Dény, P | 1 |
| Sogni, P | 1 |
| Podevin, P | 1 |
3 reviews available for adenine and Amazon Black Fever
| Article | Year |
|---|---|
Hepatitis Delta: Prevalence, Natural History, and Treatment Options.
Topics: Adenine; Antibodies, Viral; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Global Health; | 2020 |
Hepatitis B in HIV-infected patients.
Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Coinfection; Drug Resistance, Viral; Hepatitis B Vaccine | 2013 |
New advances in chronic hepatitis B.
Topics: Adenine; Antiviral Agents; Coinfection; Disease Progression; Drug Resistance, Viral; Female; Guanine | 2012 |
1 trial available for adenine and Amazon Black Fever
| Article | Year |
|---|---|
Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infection.
Topics: Adenine; Adolescent; Adult; Aged; Aleutian Mink Disease Virus; Antiviral Agents; Drug Therapy, Combi | 2012 |
9 other studies available for adenine and Amazon Black Fever
| Article | Year |
|---|---|
First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy.
Topics: Adenine; Adult; Coinfection; Hepatitis B; Hepatitis D; Humans; Male; Organophosphonates; Reverse Tra | 2015 |
Tenofovir for Hepatitis Delta.
Topics: Adenine; Hepatitis B; Hepatitis D; Humans; Male; Organophosphonates; Reverse Transcriptase Inhibitor | 2016 |
[Protocol for the antiviral therapy of hepatitis B and D].
Topics: Adenine; Antiviral Agents; Biopsy; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface | 2010 |
Liver transplantation in bearers of hepatitis B associated or not with delta hepatitis in the age of the new antiviral drugs: is hyperimmune globulin still necessary?
Topics: Adenine; Adult; Aged; Antiviral Agents; Aspartate Aminotransferases; Female; Guanine; Hepatitis B; H | 2010 |
Hepatitis: PEG-IFN for the treatment of hepatitis D.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis D; Humans; Int | 2011 |
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment.
Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; Female; gamma-Glutamyltransferase; Hepatitis | 2012 |
[Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
Topics: Adenine; Antiviral Agents; Comorbidity; Consensus; Drug Administration Schedule; Drug Therapy, Combi | 2012 |
Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection?
Topics: Acute Disease; Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepati | 2012 |
Hepatitis delta virus super-infection in a co-infected patient with the human immunodeficiency virus type 1 and a surface antigen-negative hepatitis B virus variant.
Topics: Adenine; Alanine Transaminase; Amino Acid Sequence; Anti-HIV Agents; Follow-Up Studies; Hepatitis B; | 2006 |